Research articlePublished 30 Apr 2017
Virtual Screening Identifies New Scaffolds for Testosterone 17β-Dehydrogenase (NADP+) Inhibitor
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The development of new and safer drugs is based on the use of existing physical and information resources. Furthermore, the tremendous development of the new generation of simulation techniques and advanced computer hardware provides high computing power and various molecular modeling or computational chemistry approaches over the last decade to simulate, predict, and analyze the properties and behaviors of molecules on an atomic level to perform virtual drug screening for novel drug compounds. By these computational screening, synthesized compounds are showing Testosterone 17β-dehydrogenase (NADP+) Inhibitor activity on 5EN4 and 5ICM enzymes. In that C1 and C5 are having minimum energies with 5EN4 and 5ICM where as C2 and C6 are with 4HMN and 5EN4.
Subjects
Pharmaceutical SciencesChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical and Pharmaceutical Research
- SubjectPharmaceutical Sciences
- SubjectChemistry
- BylineArticles whose byline prints “MS Harika”
- BylineArticles whose byline prints “V Renukadevi”
- BylineArticles whose byline prints “S Bhargavi”
- BylineArticles whose byline prints “S Karishma”
- BylineArticles whose byline prints “L Abbinaya”
- BylineArticles whose byline prints “L Ramya”
- BylineArticles whose byline prints “P Subhhashini”